Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Ascierto, Paolo A, MD, Arance, Ana, MD, Dutriaux, Caroline, MD, Di Giacomo, Anna Maria, MD, Rutkowski, Piotr, Prof, Del Vecchio, Michele, MD, Gutzmer, Ralf, Prof, Mandala, Mario, MD, Thomas, Luc, Prof, Demidov, Lev, Prof, Garbe, Claus, Prof, Hogg, David, MD, Liszkay, Gabriella, Prof, Queirolo, Paola, MD, Wasserman, Ernesto, MD, Ford, James, MS, Weill, Marine, MSc, Sirulnik, L Andres, MD, Jehl, Valentine, MSc, Bozón, Viviana, MD, Long, Georgina V, Prof, Flaherty, Keith, MD
Published in The lancet oncology (01.04.2017)
Published in The lancet oncology (01.04.2017)
Get full text
Journal Article
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
Basset-Seguin, Nicole, Prof, Hauschild, Axel, Prof, Grob, Jean-Jacques, Prof, Kunstfeld, Rainer, Prof, Dréno, Brigitte, Prof, Mortier, Laurent, Prof, Ascierto, Paolo A, Prof, Licitra, Lisa, MD, Dutriaux, Caroline, MD, Thomas, Luc, Prof, Jouary, Thomas, MD, Meyer, Nicolas, MD, Guillot, Bernard, Prof, Dummer, Reinhard, Prof, Fife, Kate, MD, Ernst, D Scott, Prof, Williams, Sarah, MSc, Fittipaldo, Alberto, MD, Xynos, Ioannis, MD, Hansson, Johan, Prof
Published in The lancet oncology (01.06.2015)
Published in The lancet oncology (01.06.2015)
Get full text
Journal Article
Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma
Ilie, Marius, MD, PhD, Long-Mira, Elodie, MD, Funck-Brentano, Elisa, MD, Lassalle, Sandra, MD, PhD, Butori, Catherine, MD, Lespinet-Fabre, Virginie, PhD, Bordone, Olivier, MSc, Gay, Alexandre, MSc, Zahaf, Katia, MSc, Poissonnet, Gilles, MD, Lacour, Jean-Philippe, MD, PhD, Bahadoran, Philippe, MD, PhD, Ballotti, Robert, PhD, Gros, Audrey, MD, Dutriaux, Caroline, MD, PhD, Saiag, Philippe, MD, PhD, Merlio, Jean-Philippe, MD, PhD, Vergier, Béatrice, MD, PhD, Emile, Jean François, MD, PhD, Hofman, Véronique, MD, PhD, Hofman, Paul, MD, PhD
Published in Journal of the American Academy of Dermatology (01.05.2015)
Published in Journal of the American Academy of Dermatology (01.05.2015)
Get full text
Journal Article
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional studyCapsule Summary
Léa Dousset, MD, Alize Pacaud, MD, Thomas Barnetche, PhD, Marie Kostine, MD, PhD, Caroline Dutriaux, MD, Anne Pham-Ledard, MD, PhD, Marie Beylot-Barry, MD, PhD, Emilie Gérard, MD, Sorilla Prey, MD, PhD, Nicolas Andreu, BSc, Katia Boniface, PhD, Julien Seneschal, MD, PhD
Published in JAAD international (01.12.2021)
Get full text
Published in JAAD international (01.12.2021)
Journal Article
Primary digestive melanoma in association with tubular adenoma: a case report illustrating the distinction from metastatic colonic melanoma
Furudoï, Adeline, Caumont, Charline, MD, Dutriaux, Caroline, MD, Cappellen, David, PhD, Goussot, Jean-François, MD, Vergier, Béatrice, MD, PhD, Merlio, Christine, MD, Barberis, Christophe, MD, Merlio, Jean-Philippe, MD, PhD, Gros, Audrey, PharmD, PhD
Published in Human pathology (01.02.2016)
Published in Human pathology (01.02.2016)
Get full text
Journal Article
Vitiligo-like lesions occurring in patients receiving anti-programmed cell death–1 therapies are clinically and biologically distinct from vitiligo
Larsabal, Maiana, MD, Marti, Aurélie, MD, Jacquemin, Clément, PhD, Rambert, Jérôme, PhD, Thiolat, Denis, BS, Dousset, Léa, MD, Taieb, Alain, MD, PhD, Dutriaux, Caroline, PhD, MD, Prey, Sorilla, MD, PhD, Boniface, Katia, PhD, Seneschal, Julien, MD, PhD
Published in Journal of the American Academy of Dermatology (01.05.2017)
Published in Journal of the American Academy of Dermatology (01.05.2017)
Get full text
Journal Article
Cobimetinib combined with vemurafenib in advanced BRAFV600 -mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Ascierto, Paolo A, MD, McArthur, Grant A, Prof, Dréno, Brigitte, Prof, Atkinson, Victoria, MD, Liszkay, Gabrielle, MD, Di Giacomo, Anna Maria, MD, Mandalà, Mario, MD, Demidov, Lev, MD, Stroyakovskiy, Daniil, MD, Thomas, Luc, Prof, de la Cruz-Merino, Luis, MD, Dutriaux, Caroline, MD, Garbe, Claus, Prof, Yan, Yibing, PhD, Wongchenko, Matthew, BS, Chang, Ilsung, PhD, Hsu, Jessie J, PhD, Koralek, Daniel O, PhD, Rooney, Isabelle, MBChB, Ribas, Antoni, Prof, Larkin, James, FRCP
Published in The lancet oncology (01.09.2016)
Published in The lancet oncology (01.09.2016)
Get full text
Journal Article